Elderly Patients Have Become the Leading Drug Consumers: It's High Time to Properly Evaluate New Drugs Within the Real Targeted Population
Authors:
- 10 December 2006
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (35) , e62-e63
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: A population-based studyEuropean Journal of Cancer, 2005
- Prescription Drug Use, Diagnoses, and Healthcare Utilization among the ElderlyAnnals of Pharmacotherapy, 2001
- Effect of Age and Comorbidity in Postmenopausal Breast Cancer Patients Aged 55 Years and OlderJAMA, 2001
- Perspectives on Comorbidity and Cancer in Older Patients: Approaches to Expand the Knowledge BaseJournal of Clinical Oncology, 2001
- Epidemiology of Over-the-Counter Drug Use in Community Dwelling ElderlyDrugs & Aging, 2001
- AGING AND CANCER IN AMERICAHematology/Oncology Clinics of North America, 2000
- Cancer burden in the agedCancer, 1997
- Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, the NetherlandsAnnals of Oncology, 1996
- The national institute on aging and the national cancer institute seer collaborative study on comorbidity and early diagnosis of cancer in the elderlyCancer, 1994
- Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancerBreast Cancer Research and Treatment, 1991